These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38159140)

  • 1. Optimal blood tau species for the detection of Alzheimer's disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study.
    Montoliu-Gaya L; Alosco ML; Yhang E; Tripodis Y; Sconzo D; Ally M; Grötschel L; Ashton NJ; Lantero-Rodriguez J; Sauer M; Gomes B; Nilsson J; Brinkmalm G; Sugarman MA; Aparicio HJ; Martin B; Palmisano JN; Steinberg EG; Simkin I; Turk KW; Budson AE; Au R; Farrer L; Jun GR; Kowall NW; Stern RA; Goldstein LE; Qiu WQ; Mez J; Huber BR; Alvarez VE; McKee AC; Zetterberg H; Gobom J; Stein TD; Blennow K
    Acta Neuropathol; 2023 Dec; 147(1):5. PubMed ID: 38159140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.
    Ashton NJ; Pascoal TA; Karikari TK; Benedet AL; Lantero-Rodriguez J; Brinkmalm G; Snellman A; Schöll M; Troakes C; Hye A; Gauthier S; Vanmechelen E; Zetterberg H; Rosa-Neto P; Blennow K
    Acta Neuropathol; 2021 May; 141(5):709-724. PubMed ID: 33585983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship between p-tau217, p-tau231, and p-tau205 in the Human Brain Is Affected by the Cellular Environment and Alzheimer's Disease Pathology.
    Wennström M; Schultz N; Gallardo PM; The Netherlands Brain Bank ; Serrano GE; Beach TG; Bose S; Hansson O
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies.
    Montoliu-Gaya L; Benedet AL; Tissot C; Vrillon A; Ashton NJ; Brum WS; Lantero-Rodriguez J; Stevenson J; Nilsson J; Sauer M; Rahmouni N; Brinkmalm G; Lussier FZ; Pascoal TA; Skoog I; Kern S; Zetterberg H; Paquet C; Gobom J; Rosa-Neto P; Blennow K
    Nat Aging; 2023 Jun; 3(6):661-669. PubMed ID: 37198279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ante-mortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy.
    Morrison MS; Aparicio HJ; Blennow K; Zetterberg H; Ashton NJ; Karikari TK; Tripodis Y; Martin B; Palmisano JN; Sugarman MA; Frank B; Steinberg EG; Turk KW; Budson AE; Au R; Goldstein LE; Jun GR; Kowall NW; Killiany R; Qiu WQ; Stern RA; Mez J; McKee AC; Stein TD; Alosco ML
    Brain; 2022 Oct; 145(10):3546-3557. PubMed ID: 35554506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort.
    Mendes AJ; Ribaldi F; Lathuiliere A; Ashton NJ; Janelidze S; Zetterberg H; Scheffler M; Assal F; Garibotto V; Blennow K; Hansson O; Frisoni GB
    J Neurol; 2024 Apr; 271(4):2053-2066. PubMed ID: 38195896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease.
    Therriault J; Servaes S; Tissot C; Rahmouni N; Ashton NJ; Benedet AL; Karikari TK; Macedo AC; Lussier FZ; Stevenson J; Wang YT; Fernandez-Arias J; Stevenson A; Socualaya KQ; Haeger A; Nazneen T; Aumont É; Hosseini A; Rej S; Vitali P; Triana-Baltzer G; Kolb HC; Soucy JP; Pascoal TA; Gauthier S; Zetterberg H; Blennow K; Rosa-Neto P
    Alzheimers Dement; 2023 Nov; 19(11):4967-4977. PubMed ID: 37078495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
    Thijssen EH; La Joie R; Strom A; Fonseca C; Iaccarino L; Wolf A; Spina S; Allen IE; Cobigo Y; Heuer H; VandeVrede L; Proctor NK; Lago AL; Baker S; Sivasankaran R; Kieloch A; Kinhikar A; Yu L; Valentin MA; Jeromin A; Zetterberg H; Hansson O; Mattsson-Carlgren N; Graham D; Blennow K; Kramer JH; Grinberg LT; Seeley WW; Rosen H; Boeve BF; Miller BL; Teunissen CE; Rabinovici GD; Rojas JC; Dage JL; Boxer AL;
    Lancet Neurol; 2021 Sep; 20(9):739-752. PubMed ID: 34418401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads.
    Salvadó G; Ossenkoppele R; Ashton NJ; Beach TG; Serrano GE; Reiman EM; Zetterberg H; Mattsson-Carlgren N; Janelidze S; Blennow K; Hansson O
    EMBO Mol Med; 2023 May; 15(5):e17123. PubMed ID: 36912178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology.
    Kac PR; González-Ortiz F; Emeršič A; Dulewicz M; Koutarapu S; Turton M; An Y; Smirnov D; Kulczyńska-Przybik A; Varma VR; Ashton NJ; Montoliu-Gaya L; Camporesi E; Winkel I; Paradowski B; Moghekar A; Troncoso JC; Lashley T; Brinkmalm G; Resnick SM; Mroczko B; Kvartsberg H; Gregorič Kramberger M; Hanrieder J; Čučnik S; Harrison P; Zetterberg H; Lewczuk P; Thambisetty M; Rot U; Galasko D; Blennow K; Karikari TK
    Nat Commun; 2024 Mar; 15(1):2615. PubMed ID: 38521766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylated tau in Alzheimer's disease.
    Telser J; Grossmann K; Wohlwend N; Risch L; Saely CH; Werner P
    Adv Clin Chem; 2023; 116():31-111. PubMed ID: 37852722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.
    Janelidze S; Bali D; Ashton NJ; Barthélemy NR; Vanbrabant J; Stoops E; Vanmechelen E; He Y; Dolado AO; Triana-Baltzer G; Pontecorvo MJ; Zetterberg H; Kolb H; Vandijck M; Blennow K; Bateman RJ; Hansson O
    Brain; 2023 Apr; 146(4):1592-1601. PubMed ID: 36087307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults.
    Yu L; Boyle PA; Janelidze S; Petyuk VA; Wang T; Bennett DA; Hansson O; Schneider JA
    Acta Neuropathol; 2023 Jul; 146(1):1-11. PubMed ID: 37031430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes.
    Mielke MM; Frank RD; Dage JL; Jeromin A; Ashton NJ; Blennow K; Karikari TK; Vanmechelen E; Zetterberg H; Algeciras-Schimnich A; Knopman DS; Lowe V; Bu G; Vemuri P; Graff-Radford J; Jack CR; Petersen RC
    JAMA Neurol; 2021 Sep; 78(9):1108-1117. PubMed ID: 34309632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays.
    Ashton NJ; Puig-Pijoan A; Milà-Alomà M; Fernández-Lebrero A; García-Escobar G; González-Ortiz F; Kac PR; Brum WS; Benedet AL; Lantero-Rodriguez J; Day TA; Vanbrabant J; Stoops E; Vanmechelen E; Triana-Baltzer G; Moughadam S; Kolb H; Ortiz-Romero P; Karikari TK; Minguillon C; Hernández Sánchez JJ; Navalpotro-Gómez I; Grau-Rivera O; María Manero R; Puente-Periz V; de la Torre R; Roquer J; Dage JL; Zetterberg H; Blennow K; Suárez-Calvet M
    Alzheimers Dement; 2023 May; 19(5):1913-1924. PubMed ID: 36370462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology.
    Ashton NJ; Brum WS; Di Molfetta G; Benedet AL; Arslan B; Jonaitis E; Langhough RE; Cody K; Wilson R; Carlsson CM; Vanmechelen E; Montoliu-Gaya L; Lantero-Rodriguez J; Rahmouni N; Tissot C; Stevenson J; Servaes S; Therriault J; Pascoal T; Lleó A; Alcolea D; Fortea J; Rosa-Neto P; Johnson S; Jeromin A; Blennow K; Zetterberg H
    JAMA Neurol; 2024 Mar; 81(3):255-263. PubMed ID: 38252443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals.
    Ferreira PCL; Therriault J; Tissot C; Ferrari-Souza JP; Benedet AL; Povala G; Bellaver B; Leffa DT; Brum WS; Lussier FZ; Bezgin G; Servaes S; Vermeiren M; Macedo AC; Cabrera A; Stevenson J; Triana-Baltzer G; Kolb H; Rahmouni N; Klunk WE; Lopez OL; Villemagne VL; Cohen A; Tudorascu DL; Zimmer ER; Karikari TK; Ashton NJ; Zetterberg H; Blennow K; Gauthier S; Rosa-Neto P; Pascoal TA
    Alzheimers Dement; 2023 Oct; 19(10):4463-4474. PubMed ID: 37534889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between ante mortem Alzheimer's disease biomarkers in predicting neuropathology at autopsy.
    Wang ZB; Tan L; Wang HF; Chen SD; Fu Y; Gao PY; Ma YH; Guo Y; Hou JH; Zhang DD; Yu JT;
    Alzheimers Dement; 2023 Aug; 19(8):3613-3624. PubMed ID: 36840620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231.
    Bayoumy S; Verberk IMW; den Dulk B; Hussainali Z; Zwan M; van der Flier WM; Ashton NJ; Zetterberg H; Blennow K; Vanbrabant J; Stoops E; Vanmechelen E; Dage JL; Teunissen CE
    Alzheimers Res Ther; 2021 Dec; 13(1):198. PubMed ID: 34863295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays.
    Leuzy A; Janelidze S; Mattsson-Carlgren N; Palmqvist S; Jacobs D; Cicognola C; Stomrud E; Vanmechelen E; Dage JL; Hansson O
    Neurology; 2021 Oct; 97(17):e1681-e1694. PubMed ID: 34493616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.